PHOENIX, Sept. 23,
2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES),
the rodent fertility control experts and inventors of the only EPA
registered contraceptive for male and female rats, announced today
it will participate in a webcasted presentation and host one-on-one
meetings with investors at the Lytham Partners Fall 2024 Investor
Conference, taking place virtually on Tuesday, October 1, 2024.
Company Webcast
The webcasted presentation will take place at 11:00am ET on
Tuesday, October 1, 2024. The webcast
can be accessed by visiting the conference home page at
https://lythampartners.com/fall2024/ or directly at
https://app.webinar.net/yOrYbRyQg8o. The webcast will also be
available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register
for the event at
https://lythampartners.com/fall2024invreg/.
About SenesTech
We are committed to improving the health of the world by
humanely managing animal pest populations through our expertise in
fertility control. We invented ContraPest, the only U.S.
EPA-registered contraceptive for male and female rats, as well as
Evolve and Evolve Mouse, EPA-designated minimum risk contraceptives
for rodents, reflecting our mission to provide products that are
proactive, safe and sustainable. ContraPest and Evolve fit
seamlessly into all integrated pest management programs,
significantly improving the overall goal of effective pest
management. We strive for clean cities, efficient businesses and
happy households – with a product designed to be humane, effective
and sustainable.
For more information visit https://senestech.com/.
Safe Harbor
Statement
This press release contains "forward-looking statements"
within the meaning of federal securities laws, and we intend that
such forward-looking statements be subject to the safe harbor
created thereby. Forward-looking statements may describe
future expectations, plans, results or strategies and are often,
but not always, made through the use of words such as "believe,"
"may," "future," "plan," "will," "should," "expect," "anticipate,"
"eventually," "project," "estimate," "continuing," "intend" and
similar words or phrases. You are cautioned that such
statements are subject to risks, uncertainties and other factors
that could cause actual results to differ materially from those
reflected by such forward-looking statements. Such factors
include, among others, the successful commercialization of our
products; market acceptance of our products; our financial
performance, including our ability to fund operations; our ability
to regain and maintain compliance with Nasdaq's continued listing
requirements; and regulatory approval and regulation of our
products and other factors and risks identified from time to time
in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K for the fiscal year ended
December 31, 2023. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date.
Except as required by law, we do not undertake any obligation to
publicly update any forward-looking statements, whether as a result
of the receipt of new information, the occurrence of future events
or otherwise.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-fall-2024-investor-conference-on-october-1-2024-302255006.html
SOURCE SenesTech, Inc.